Immunovia to present at the Redeye Technology & Life Science Day
LUND (SWEDEN) – Immunovia (IMMNOV: Nasdaq Stockholm), the pancreatic cancer diagnostics company, will present at the Redeye Technology & Life Science Day on December 3, hosted by Redeye. Redeye Technology & Life Science Day gathers over 40 leading Nordic companies for a live-streamed event to showcase the groundbreaking work of these companies. During the event, Immunovia CEO Jeff Borcherding will be present in Stockholm to share the company’s latest developments. Event attendees are encouraged to take the opportunity to meet with Jeff and Immunovia’s CFO, Karin Almqvist-